Filtrar por Last updated date SelectDespués deAntes deFrom - To Date Fecha de final Esta semana Este mes la semana pasada El mes pasado Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationMedicine shortagesResearch and developmentBiosimilarsSMEAntimicrobial resistanceCorporateGovernanceBrexitQuality of medicinesGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate usePRIMECareersMedication errorParallel distributionProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety information Patient safety Deje este campo en blanco Filter Resultados (3844) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Deje este campo en blanco Public statement on Insuman Infusat 100-IU/ml solution for injection in cartridges of 3.15 ml (insulin human) - Risk of leakage during use 14 Febrero 2000News Committee for veterinary medicinal products: 52nd meeting 10 Febrero 2000Press releaseVeterinary Public Statement on Ziagen (Abacavir) - Important safety Information on Hypersensitivity Reactions and Respiratory Symptoms 24 Enero 2000News Committee for Proprietary Medicinal Products (CPMP) 56th plenary meeting 24 Enero 2000Press release 3rd meeting of the Committee for Orphan Medicinal Products 19 Enero 2000Press releaseHumanRare diseases Committee for veterinary medicinal products: 51st meeting 13 Enero 2000Press releaseVeterinary Public Statement on Rapilysin (Reteplase) - Incompatibility with Heparin and Precipitation following the Reconstitution - Important New Instructions for Use 23 Diciembre 1999News Committee for Proprietary Medicinal Products (CPMP) 55th plenary meeting 20 Diciembre 1999Press release Public Statement on Levacetylmethadol (Orlaam) - Life Threatening Cardiac Rhythm Disorders 15 Diciembre 1999News Committee for veterinary medicinal products: 50th meeting 9 Diciembre 1999Press releaseVeterinary 1 … 367 368 369 370 371 Page 371 of 385 372 373 374 375 … 385
Public statement on Insuman Infusat 100-IU/ml solution for injection in cartridges of 3.15 ml (insulin human) - Risk of leakage during use 14 Febrero 2000News
Public Statement on Ziagen (Abacavir) - Important safety Information on Hypersensitivity Reactions and Respiratory Symptoms 24 Enero 2000News
3rd meeting of the Committee for Orphan Medicinal Products 19 Enero 2000Press releaseHumanRare diseases
Public Statement on Rapilysin (Reteplase) - Incompatibility with Heparin and Precipitation following the Reconstitution - Important New Instructions for Use 23 Diciembre 1999News
Committee for Proprietary Medicinal Products (CPMP) 55th plenary meeting 20 Diciembre 1999Press release
Public Statement on Levacetylmethadol (Orlaam) - Life Threatening Cardiac Rhythm Disorders 15 Diciembre 1999News
